Feasibility, toxicity, and efficacy of short induction chemotherapy of docetaxel plus cisplatin or carboplatin (TP) followed by concurrent chemoradio-therapy for organ preservation in advanced cancer of the hypopharynx, larynx, and base of tongue. Early results.

Sabine Semrau; Frank Waldfahrer; Michael Lell; Rainer Linke; Gunther Klautke; Torsten Kuwert; Michael Uder; Heinrich Iro; Rainer Fietkau

doi:10.1007/s00066-010-2178-2

Feasibility, toxicity, and efficacy of short induction chemotherapy of docetaxel plus cisplatin or carboplatin (TP) followed by concurrent chemoradio-therapy for organ preservation in advanced cancer of the hypopharynx, larynx, and base of tongue. Early results.

Sabine Semrau
, Frank Waldfahrer
, Michael Lell (Co-Autor/-in)
, Rainer Linke
, Gunther Klautke
, Torsten Kuwert
, Michael Uder
, Heinrich Iro
, Rainer Fietkau

Publikation: Beitrag in Fachzeitschrift › Originalarbeit › Begutachtung

28 Quellenangaben (Web of Science)

Originalsprache	Englisch
Seiten (von - bis)	15-22
Fachzeitschrift	STRAHLENTHERAPIE UND ONKOLOGIE
Jahrgang	187
Ausgabenummer	1
DOIs	https://doi.org/10.1007/s00066-010-2178-2
Publikationsstatus	Veröffentlicht - 2011

Zugriff auf Dokument

10.1007/s00066-010-2178-2

Dieses zitieren

Semrau, S., Waldfahrer, F., Lell, M., Linke, R., Klautke, G., Kuwert, T., Uder, M., Iro, H., & Fietkau, R. (2011). Feasibility, toxicity, and efficacy of short induction chemotherapy of docetaxel plus cisplatin or carboplatin (TP) followed by concurrent chemoradio-therapy for organ preservation in advanced cancer of the hypopharynx, larynx, and base of tongue. Early results. STRAHLENTHERAPIE UND ONKOLOGIE , 187(1), 15-22. https://doi.org/10.1007/s00066-010-2178-2

Semrau, Sabine ; Waldfahrer, Frank ; Lell, Michael et al. / Feasibility, toxicity, and efficacy of short induction chemotherapy of docetaxel plus cisplatin or carboplatin (TP) followed by concurrent chemoradio-therapy for organ preservation in advanced cancer of the hypopharynx, larynx, and base of tongue. Early results. in: STRAHLENTHERAPIE UND ONKOLOGIE 2011 ; Jahrgang 187, Nr. 1. S. 15-22.

@article{64e6703e1cfc4a2fad2a5f140a506968,

title = "Feasibility, toxicity, and efficacy of short induction chemotherapy of docetaxel plus cisplatin or carboplatin (TP) followed by concurrent chemoradio-therapy for organ preservation in advanced cancer of the hypopharynx, larynx, and base of tongue. Early results.",

keywords = "LOCALLY ADVANCED HEAD, SQUAMOUS-CELL CARCINOMA, PHASE-III TRIAL, NECK-CANCER, HYPERFRACTIONATED RADIOTHERAPY, SIMULTANEOUS RADIOCHEMOTHERAPY, RADIATION-THERAPY, UNRESECTABLE HEAD, FLUOROURACIL, PACLITAXEL",

author = "Sabine Semrau and Frank Waldfahrer and Michael Lell and Rainer Linke and Gunther Klautke and Torsten Kuwert and Michael Uder and Heinrich Iro and Rainer Fietkau",

year = "2011",

doi = "10.1007/s00066-010-2178-2",

language = "English",

volume = "187",

pages = "15--22",

journal = "STRAHLENTHERAPIE UND ONKOLOGIE ",

issn = "0179-7158",

publisher = "Springer Nature",

number = "1",

}

Semrau, S, Waldfahrer, F, Lell, M, Linke, R, Klautke, G, Kuwert, T, Uder, M, Iro, H & Fietkau, R 2011, 'Feasibility, toxicity, and efficacy of short induction chemotherapy of docetaxel plus cisplatin or carboplatin (TP) followed by concurrent chemoradio-therapy for organ preservation in advanced cancer of the hypopharynx, larynx, and base of tongue. Early results.', STRAHLENTHERAPIE UND ONKOLOGIE , Jg. 187, Nr. 1, S. 15-22. https://doi.org/10.1007/s00066-010-2178-2

Feasibility, toxicity, and efficacy of short induction chemotherapy of docetaxel plus cisplatin or carboplatin (TP) followed by concurrent chemoradio-therapy for organ preservation in advanced cancer of the hypopharynx, larynx, and base of tongue. Early results. / Semrau, Sabine; Waldfahrer, Frank; Lell, Michael (Co-Autor/-in) et al.
in: STRAHLENTHERAPIE UND ONKOLOGIE , Jahrgang 187, Nr. 1, 2011, S. 15-22.

Publikation: Beitrag in Fachzeitschrift › Originalarbeit › Begutachtung

TY - JOUR

T1 - Feasibility, toxicity, and efficacy of short induction chemotherapy of docetaxel plus cisplatin or carboplatin (TP) followed by concurrent chemoradio-therapy for organ preservation in advanced cancer of the hypopharynx, larynx, and base of tongue. Early results.

AU - Semrau, Sabine

AU - Waldfahrer, Frank

AU - Lell, Michael

AU - Linke, Rainer

AU - Klautke, Gunther

AU - Kuwert, Torsten

AU - Uder, Michael

AU - Iro, Heinrich

AU - Fietkau, Rainer

PY - 2011

Y1 - 2011

KW - LOCALLY ADVANCED HEAD

KW - SQUAMOUS-CELL CARCINOMA

KW - PHASE-III TRIAL

KW - NECK-CANCER

KW - HYPERFRACTIONATED RADIOTHERAPY

KW - SIMULTANEOUS RADIOCHEMOTHERAPY

KW - RADIATION-THERAPY

KW - UNRESECTABLE HEAD

KW - FLUOROURACIL

KW - PACLITAXEL

U2 - 10.1007/s00066-010-2178-2

DO - 10.1007/s00066-010-2178-2

M3 - Original Article

C2 - 21234526

SN - 0179-7158

VL - 187

SP - 15

EP - 22

JO - STRAHLENTHERAPIE UND ONKOLOGIE

JF - STRAHLENTHERAPIE UND ONKOLOGIE

IS - 1

ER -

Semrau S, Waldfahrer F, Lell M, Linke R, Klautke G, Kuwert T et al. Feasibility, toxicity, and efficacy of short induction chemotherapy of docetaxel plus cisplatin or carboplatin (TP) followed by concurrent chemoradio-therapy for organ preservation in advanced cancer of the hypopharynx, larynx, and base of tongue. Early results. STRAHLENTHERAPIE UND ONKOLOGIE . 2011;187(1):15-22. doi: 10.1007/s00066-010-2178-2